Viral ‘Molecule’ Pill Sparks Health Crisis Among Russian Teens

Moscow– A dangerously addictive weight-loss pill dubbed “Molecule” is surging in popularity among Russian teenagers, fueled by TikTok influencers and black-market sales, leading to a wave of hospitalizations and urgent calls for a nationwide ban.

Promoted as a “miracle” slimming aid, the unregulated capsules—sold for as little as 200 rubles ($2) per pack on Telegram channels—promise rapid fat loss without diet or exercise. Recent lab tests by Russian health authorities have confirmed the pills contain sibutramine, a banned appetite suppressant pulled from global markets in 2010 over links to heart attacks and strokes, alongside unlisted stimulants like caffeine and ephedrine.  Users as young as 14 report severe side effects, including palpitations, nausea, insomnia, and fainting, with emergency room visits among adolescents spiking 30% in major cities like Moscow and St. Petersburg over the past month.
Twenty-two-year-old Maria Ivanovna, a former user from Yekaterinburg, shared her ordeal with the BBC: “I lost 10 kilos in two weeks, but then my heart started racing so fast I blacked out. It’s not worth it—doctors say it could have killed me.” Experts warn the drug’s low cost and viral hype, amplified by influencers flaunting “before-and-after” transformations, exploit body image insecurities amid Russia’s rising youth obesity rates.
Russia’s Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) has launched raids on illicit sellers, seizing thousands of packets, but the underground trade persists. Pediatrician Dr. Elena Petrova told state media: “This is a ticking time bomb for our youth—addiction risks and organ damage could scar a generation.”

As awareness grows, social media campaigns urge teens to #DitchMolecule, but officials say stricter platform regulations are needed to curb the spread. With winter holidays approaching, health advocates fear a fresh surge in misuse.

Related Posts

Centre flags serious lapses in state’s blood banks

Jaipur: Union health ministry has flagged “serious lapses” in Rajasthan’s blood bank management after inspections found shortcomings including inadequate record-keeping, lack of proper ELISA testing, and failures to communicate HIV-positive…

Sun Pharma Launches UNLOXCYT for Advanced Skin Cancer in US

New Delhi: Sun Pharmaceutical Industries Limited has announced that UNLOXCYT (cosibelimab-ipdl) is now available in the United States for prescription by healthcare professionals for the treatment of adults with metastatic…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Centre flags serious lapses in state’s blood banks

Centre flags serious lapses in state’s blood banks

Sun Pharma Launches UNLOXCYT for Advanced Skin Cancer in US

Sun Pharma Launches UNLOXCYT for Advanced Skin Cancer in US

Unlicensed medical device stock worth Rs. 4.47 lakh seized in Gurugram raid

Unlicensed medical device stock worth Rs. 4.47 lakh seized in Gurugram raid

Controlled substances charge: Court summons Ramdev, Amazon founder

Controlled substances charge: Court summons Ramdev, Amazon founder

Allahabad HC refuses to quash case against pharma company linked to cough syrup deaths in Uzbekistan

Allahabad HC refuses to quash case against pharma company linked to cough syrup deaths in Uzbekistan

IPC registers 44 small-scale medtech firms under ADRMS

IPC registers 44 small-scale medtech firms under ADRMS